December

Targeted therapy in respiratory disease Brian D. Kent Breathe, 17 (4) 210170; 10.1183/20734735.0170-2021
The COVID-19 surge in Indonesia: what we learned and what to expect Eric Daniel Tenda, Moses Mazmur Asaf, Ariel Pradipta, Meutia Ayuputeri Kumaheri, Anindya Pradipta Susanto Breathe, 17 (4) 210146; 10.1183/20734735.0146-2021
Patient experiences of biologic treatment for severe asthma: the good, the outstanding and the deeply frustrating Jessica Denning, Jenny Negus, Niamh Cullen Breathe, 17 (4) 210145; 10.1183/20734735.0145-2021
Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim? Lauren A. Quinn, Sunaya H. Hirani, Thomas C. Williams, Ian P. Sinha Breathe, 17 (4) 210110; 10.1183/20734735.0110-2021
A pragmatic guide to choosing biologic therapies in severe asthma Joanne E. Kavanagh, Andrew P. Hearn, David J. Jackson Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy Daniel H. Tewkesbury, Rebecca C. Robey, Peter J. Barry Breathe, 17 (4) 210112; 10.1183/20734735.0112-2021
The use of treatable traits to address COPD complexity and heterogeneity and to inform the care Katarzyna Duszyk, Rebecca F. McLoughlin, Peter G. Gibson, Vanessa M. McDonald Breathe, 17 (4) 210118; 10.1183/20734735.0118-2021
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy Gokul Erumbala, Sabu Anzar, Amjad Tonbari, Ramadan Salem, Colin Powell Breathe, 17 (4) 210113; 10.1183/20734735.0113-2021
Precision medicine in bronchiectasis Thomas Pembridge, James D. Chalmers Breathe, 17 (4) 210119; 10.1183/20734735.0119-2021
In pursuit of the primary Jane Mendonca, Vishak Acharya, Sanyo D'souza, Kausalya Kumari Sahu, Sindhu Kamath, Jyoti R. Kini Breathe, 17 (4) 210142; 10.1183/20734735.0142-2021
A young man with transitory hemiparesis and lung infiltrates Anja Ljilja, Niko Radovic, Jasna Tekavec-Trkanjec Breathe, 17 (4) 210069; 10.1183/20734735.0069-2021
First report of a very rare complication in a case of nonsmall cell lung carcinoma Inês Moreira, Ana Sofia Vilariça, Paula Alves Breathe, 17 (4) 210107; 10.1183/20734735.0107-2021
A case of haemoptysis and bilateral areas of lung consolidation sparing the right lower lobe Nadia Corcione, Antonio Ponticiello, Severo Campione, Alfonso Pecoraro, Livio Moccia, Giuseppe Failla Breathe, 17 (4) 210072; 10.1183/20734735.0072-2021
Syncope: a complication of chronic cough Jenny King, Sarah Hennessey, James Wingfield Digby, Jaclyn Ann Smith, Paul Marsden Breathe, 17 (4) 210094; 10.1183/20734735.0094-2021
ERS ECM Awardee 2021, a preview of LSC 2022 and a brief overview of the Respiratory Channel João C. Costa, Philip Mitchelmore, Niki D. Ubags, Cristina Calarasu, Holly R. Keir, Joana Cruz Breathe, 17 (4) 210121; 10.1183/20734735.0121-2021
Contribution of causal factors to disease burden: how to interpret attributable fractions Emilie Counil Breathe, 17 (4) 210086; 10.1183/20734735.0086-2021
Lung cancer screening by volume computed tomography: thriving to high performance Eline Schillebeeckx, Kevin Lamote Breathe, 17 (4) 210063; 10.1183/20734735.0063-2021
Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death? Melissa J. McDonnell, Michael Harrison, Robert M. Rutherford Breathe, 17 (4) 210046; 10.1183/20734735.0046-2021
Choosing pharmacotherapy for ILD in patients with connective tissue disease Zhe Wu, Philip L. Molyneaux Breathe, 17 (4) 210114; 10.1183/20734735.0114-2021
Breathe, list of peer reviewers 2021 Breathe, 17 (4) 211741; 10.1183/20734735.1741-2021